Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: Beyond β-blockers

Pharmacotherapy

Volumn 30, Issue 7, 2010, Pages

  Davis, Estella M ^a   Packard, Kathleen A ^a   Hilleman, Daniel E ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Cardiac surgery; Cardiothoracic surgery; Postoperative atrial fibrillation; Prophylaxis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; AMIODARONE; ASCORBIC ACID; ATENOLOL; CORTICOSTEROID DERIVATIVE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIOTHYRONINE; MAGNESIUM; METOPROLOL; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PLACEBO; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; LIVER TOXICITY; LUNG TOXICITY; PROPHYLAXIS; QT PROLONGATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; THYROID DISEASE; VISUAL DISORDER; DRUG ANTAGONISM; HOSPITAL COST; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD;

ACETYLCYSTEINE; ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CARDIAC SURGICAL PROCEDURES; DIGOXIN; FATTY ACIDS, OMEGA-3; HOSPITAL COSTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; POSTOPERATIVE PERIOD; RECEPTORS, ANGIOTENSIN; SOTALOL;

EID: 77954125596     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.7.749     Document Type: Review

References (143)

1. Bradley D, Creswell LL, Hogue CW, Epstein AE, Prystowsky EN, Daoud EG. American college of chest physicians guidelines for the prevention and management of Postoperative atrial fibrillation after cardiac surgery. Chest 2005;128(2):39S-47S.
2. Dunning J, Treasure T, Versteegh M, Samer AM, and the EACTS Audit and Guidelines Committee. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. eur J Cardiothor Surg 2006;30:852-872.
3. Echahidi N, Pibarot P, O'hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Amer Col Card 2008;51(8):793-801.
4. Kaireviciute D, Aidietis A, Lip GY. Atrial fibrillation following cardiac surgery: clinical features and preventive strategies. eur Heart J 2009;30:410-425.
5. Kim MH, Deeb GM, Morady F, et al. effect of postoperative atrial fibrillation on length of stay after cardiac surgery (The Postoperative Atrial Fibrillation in Cardiac Surgery Study [PACS]). Am J Cardiol 2001;87:881-885.
6. Zimmer J, Pezzullo J, Choucair W, et al. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 2003;91:1137-1140.
7. Gillespie EL, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2006;26:499-504.
8. Aranski SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94:390-397.
9. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the european heart rhythm society. Circulation 2006;114:700-752. (Pubitemid 44252312)
10. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 Guideline update for coronary artery bypass graft surgery: summary article. A report of the American college of cardiology/American heart association task force on practice guidelines (Committee to update the 1999 guidelines for coronary artery bypass graft surgery). J Amer Col Card 2004;44:e213-310.
11. Surgical Care Improvement Project National Hospital Inpatient Quality Measures. version 3.0a. Set Measure ID#: SCIP-Card-2. Specifications Manual for National Hospital Inpatient Quality Measures. Available from http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/ Current+NHQM+Manual.htm. Accessed March 13, 2009.
12. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002;106:75-80.
13. Kalman JM, Munawar M, Howes LG et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995;60:1709-15.
14. Jideus L, Blomstrom P, Nilsson L et al. Tachyarrhythmias and triggering factors for atrial fibrillation after coronary artery bypass operations. Ann Thorc Surg 2000;69:1064-9.
15. Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, Coleman CI. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thor Cardiovasc Surg 2008;135:405-411.
16. Behmanesh S, tossios P, Homedan H, et al. effect of prophylactic bisoprolol plus magnesium on the incidence of atrial fibrillation after coronary bypass surgery: results of a randomized controlled trial. Curr Med Res Opinion 2006;22(8):1443-1450.
17. Forlani S, DePaulis R, de Notaris S, et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2002;74:720-726.
18. Auer J, Weber T, Berent R, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 2004;147:636-643.
19. Giri S, White CM, Dunn AB, et al. Oral amiodarone for the prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebocontrolled trial. lancet 2001;357:830-836.
20. Mathew JP, Fontes ML, Tudor JC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. J Am Med Assoc 2004;291:1720-1729.
21. Baker WL, White CM. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother 2007;41:587-598.
22. Nisanoglu V, Aldemir M, Ozgur B, et al. Atrial fibrillation aftery coronary artery bypass grafting in elderly patients: incidence and risk factor analysis. Thorac Cardiovasc Surg 2007;55:32-38.
23. Barnes BJ, Kirkland EA, Howard PA, et al. Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann Thorac Surg 2006;82:1332-1337.
24. Kalman JM, Munawar M, Howes LG, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1991;52:529-533.
25. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? . Circulation 2003;108(Suppl 1:II):195-199.
26. Bruins P, Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96(10):3542-3548. (Pubitemid 27513431)
27. Canbaz S, Erbas H, Huseyin S, Duran E. The role of inflammation in atrial fibrillation following open heart surgery. J Int Med Res 2008;36:1070-1077.
28. Erlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. eur Heart J 2006;27:512-518.
29. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? eur Heart J 2006;27:136-149.
30. Lamm G, Auer J, Weber T, Berent R, Ng C, Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothroac vasc Anesth 2006;20:51-56.
31. Ishii T, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005;111(22):2881-2888.
32. Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 2006;135(1):68-75.
33. Rodrigo R, Cereceda M, Castillo R, et al. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol Ther 2008;118:104-127.
34. Ramlawi B, Otu H, Mieno S, et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case control study. Ann Thorac Surg 2007;84:1166-1173.
35. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Amer Col Card 2008;51:68-74.
36. Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stressmediated myocardial injury phenomenon. eur J Cardiovasc Prev Rehab 2008;15:735-741.
37. Griendling KK, Sorescu D, Ushio Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501. (Pubitemid 30165039)
38. Wijeysundera DN, Beattie WS, Rao V, Karski J. Calcium antagonists reduce cardiovascular complications after cardiac surgery. J Amer Col Card 2003;41:1496-1505.
39. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. Circulation 1991;84(Suppl. III):236-244.
40. Woodend AK, Nichol G, Carey CY, Tang ASL. Sotalol confers no additional benefit over β-blockers in post-coronary artery bypass atrial fibrillation. J Amer Col Card 1998;31:383 (Abstract).
41. Janssen J, Loomans L, Harink J, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology 1986;37(8):601-609. (Pubitemid 16044309)
42. Suttorp MJ, Kingma JH, Peels HOJ, et al. effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 1991;68:1163-1169.
43. Weber UK, Osswald S, Huber M, et al. Selective versus nonselective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for preoperative risk stratification? eur Heart J 1998;19:794-800.
44. Evrard P, Gonzalez M, Jamart J, et al. Prophylaxis of supraventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg 2000;70:151-156.
45. Jacquet L, Evenepoel M, Marenne F, et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. J Cardiothorac vasc Anes 1994;8(4):431-436.
46. Wurdeman RL, Mooss AN, Mohiuddin SM, Lenz TL. Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. Chest 2002;121:1203-1210.
47. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. eur Heart J 2006;27:2846-2857.
48. Parikka H, Toivonen L, Heikkila L, Virtanen K, Jarvinen A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol 1998;31(1):67-73.
49. Sanjuan R, Blasco M, Carbonell N, et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg 2004;77:838-843.
50. Suttorp MJ, Kingma JH, Gin MTJ, et al. efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thor Cardiovasc Surg 1990;100:921-926.
51. Nystrom U, Edvardssin N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surgeon 1993;41:34-37. (Pubitemid 23090267)
52. Aerra V, Kudvalli M, Moloto AN, et al. Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis. J Cardiothorac Surg 2006;1:6.
53. Mooss AN, Wurdeman RL, Sugimoto JT, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the reduction in postoperative cardiovascular arrhythmic events (REDUCE) trial. Am Heart J 2004;148:641-648.
54. Daoud EG, Strickberger SA, Ching Man K, al. e. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. NEJM 1997;337:1785-1791.
55. Guarnieri T, Nolan S, Gottlieb SO, Dudeck A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial. J Amer Col Card 1999;34:343-347.
56. Giri S, White CM, Dunn AB, et al. Oral amiodarone for the prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebocontrolled trial. lancet 2001;357:830-836.
57. White DM, Giri S, Tsikouris JP, et al. A comparison of two individual amiodarone regimens to placebo in open heart patients. Ann Thorac Surg 2002;74:69-74.
58. Yazigi A, Rahbani P, Zeid HA, Madi-Jebara S, Haddad F, Hayek G. Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. Cardiothorac vasc Anesth 2002;16:603-606.
59. Tokmakoglu H, Kandemir O, Gunaydin S, Catav Z, Yorgancioglu C, Zorlutuna Y. Amiodarone versus digoxin and metoprolol combination for the prevention for post coronary bypass atrial fibrillation. eur J Cardiothor Surg 2002;21:401-405.
60. White CM, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracis surgery atrial fibrillation: The Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003;108(Suppl. II):II200-II206.
61. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: A randomized controlled trial. J Am Med Assoc 2005;294:3093-3100.
62. Budeus M, Hennersdorf M, Perings S, et al. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebocontrolled, randomized study. eur Heart J 2006;27:1584-1591.
63. Zebis LR, Christensen TD, Thomsen HF, et al. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. Ann Thorac Surg 2007;83:1326-1331.
64. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomized, double blind, placebo controlled trial. Br Heart J 1993;70:56-60. (Pubitemid 23243746)
65. Redle JD, Khurana S, Marzan R, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999;138:144-150.
66. Treggiari-Venzi MM, Waeber JL, Perneger TV, Suter PM, Adamec R, romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000;85:690-695.
67. Mikroulis D, Didilis V, Konstantinou F, Tsakiridis K, Vretzakis G, Bougioukas G. Diltiazem versus amiodarone to prevent atrial fibrillation in coronary surgery. Asian Cardiovasc Thorac Ann 2005;13:47-52. (Pubitemid 40613206)
68. Cardona F, Seide H, Cox R, Perez C. effect of right atrial pacing, intravenous amiodarone and β blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study. Puerto Rico Heart Surg J 2003;22:119-123.
69. Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Int Med 2005;143:327-336.
70. Gillespie EL, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM. effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother 2005;39:1409-1415.
71. Buckley MS, Nolan PE, Slack MK, Tisdale JE, Hilleman DE, Copeland JG. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacother 2007;27:360-368.
72. Solomon AJ, Greenberg MD, Kilborn MJ, Katz NM. Amiodarone versus a β-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 2001;142:811-815.
73. Kerstein J, Soodan A, Qama M, et al. Giving Iv and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 2004;126:716-724.
74. Cagli K, Ozeke O, Ergun K, et al. effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary surgery. J Cardiac Surg 2006;21:458-464.
75. Nydard E, sorensen L, Hviid L, et al. effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. J Cardiothorac vasc Anes 2004;18:709-714.
76. Perkerson KA, Gillespie EL, White CM, et al. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacother 2005;25:320-324.
77. Patel AA, White CM, Gillespie EL, Kluger J, Coleman CI. Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm 2006;63:829-837.
78. Serafimovski N, Burke P, Khawaja O, Sekulic M, Machado C. usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting. Am J Cardiol 2008;101:1574-1579.
79. Caspie J, rudis E, Bar I, Safadi T, Saute M. effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 1995;59:942-947.
80. Bert AA, Reinert SE, Singh AK. A B-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothroac vasc Anesth 2001;15(2):204-209.
81. Zangrillo A, Londoni G, Sparicio D, et al. Perioperative magnesium supplementation to prevent atrial fibrillation after offpump coronary artery surgery: a randomized controlled study. J Cardiothorac vasc Anes 2005;19(6):723-728.
82. Wilkes NJ, Mallett SV, Peachey T, DiSalvo C, Walesby R. Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 2002;95:828-834.
83. Colquhoun IW, Berg GA, El-Fiky M, Hurle A, Fell GS, Wheatley DJ. Arrhythmia prophylaxis after coronary artery surgery. eur J Cardiothor Surg 1993;7:520-523.
84. Shakerinia T, Ali IM, Sullivan JAP. Magnesium in cardioplegia: is it necessary? . Can J Surg 1996;39(5):397-400.
85. Nurozler F, Tokgozoglu L, Pasaoglu I, Boke E, Ersoy U, Bozer AY. Atrial fibrillation after coronary artery bypass surgery: predictors and the role of MgSO4 replacement. J Cardiac Surg 1996;11:421-427. (Pubitemid 27133465)
86. Maslow AD, Regan MM, Heindle S, Panzica P, Cohn WE, Johnson RG. Postoperative atrial tachyarrhythmias in patients undergoing coronary artery bypass graft surgery without cardiopulmonary bypass: a role for intraoperative magnesium supplementation. J Cardiothorac vasc Anes 2000;14(5):524-530.
87. Kohno H, Koyanagi T, Kasegawa H, Miyazaki M. Three day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2005;79:117-126.
88. Wistbacka JOM, Koistinen J, Karlqvist KEV, et al. Magnesium substitution in elective coronary artier surgery: a double-blind clinical study. J Cardiothorac vasc Anes 1995;9(2):140-146.
89. Solomon AJ, Berger AK, Trivedi KK, Hannan RL, Katz NM. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg 2000;69:126-129.
90. Geertman H, Van der Starre PJA, Sie HT, Beukema WP, van Rooyen-Butijn M. Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. J Cardiothorac Anesth 2004;18(3):309-312.
91. Shiga T, Wajima Z, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med 2004;117:325-333.
92. Miller S, Crystal E, Garfinkle M, Lau C, Lashevsky I, Connolly SJ. effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 2005;91:618-623.
93. Alghamdi AA, Al-Radi OO, Latter DA. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: as systemic review and meta-analysis. J Cardiac Surg 2005;20:293-299.
94. Henyan NN, Gillespie EL, White CM, Kluger J, Coleman CI. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg 2005;80:2402-2406. (Pubitemid 41718112)
95. Shepherd J, Jones J, Framptom GK, Tanajewski L, Turner D, Price A. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation. Health Tech Assess 2008;12(28):1-95.
96. Tsai CT, Lai lP, Lin JL. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004;109:1640-1646.
97. Makkar KM, Sanoski CA, Spinler SA. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Pharmacother 2009;29:31-48.
98. Ozaydin M, Dede O, Varol E, et al. effect of renin-angoitensin aldosterone system blockers on postoperative atrial fibrillation. Int J Cardiol 2008;127:362-367.
99. White CM, Kluger J, Lertsburapa K, Faheem O, Coleman CI. effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. eur J Cardiothor Surg 2007;31:817-820.
100. Coleman CI, Makanji S, Kluger J, White CM. effect of angiotensin- converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann Pharmacother 2007;41:433-437.
101. Paraskevas KI. Applications of statins in cardiothoracic surgery: more than just lipid lowering. eur J Cardiothor Surg 2008;33:377-390.
102. Howard PA, Barnes BJ. Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery. Ann Pharmacother 2008;42:253-258.
103. Chello M, Patti G, Candura D, et al. effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006;34:660-667.
104. Patel AA, White CM, Shah SA, Dale KM, Kluker J, Coleman CI. The relationship between statin use and atrial fibrillation. Curr Med Res Opinion 2007;23:1177-1185.
105. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery- results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) Study. Circulation 2006;114:1455-1461.
106. Song YB, Keun Y, Hyung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J 2008;156:373e379-373e316.
107. Subramaniam K, Koch C, Allen B, et al. Preoperative statin use is associated with a reduction in postoperative atrial arrhythmias in isolated coronary artery bypass grafting. Anesth Analg 2005;100:SCA1-116 (Abstract SCA110).
108. Mariscalco G, Lorusso R, Klersy C, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007;84:1158-1165.
109. Ozaydin M, Dogan A, Varol E, et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007;107:117-121.
110. Thielmann M, Neuhauser M, Marr A, et al. lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thor Cardiovasc Surg 2007;134:1143-1149.
111. Dotani MI, Elnicki DM, Jain AC, Gibson CM. effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000;86:1128-1130.
112. Laikopoulos OJ, Choi YH, Haldenwang PL, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30000 patients. eur Heart J 2008;29:1548-1559.
113. Kourlioros A, DeSouza A, Roberts N, et al. Dose-related effects of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 2008;85:1515-1520.
114. FDA Alert 8/8/2008. Information for Healthcare Professionals - Simvastatin (marketed as Zocor and generics), ezetimibe/Simvastatin (marketed as vytorin), Niacin extendedrelease/Simvastatin (marketed as Simcor), used with Amiodarone (Cordarone, Pacerone) Available from http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124362.htm. Accessed on October 10, 2009.
115. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-2891.
116. Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001;56:375-380.
117. Cheruku KK, Ghani A, Ahmad F, et al. efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol 2004;7:13-18.
118. Ruffin RT, Kluger J, Baker WM, Wills SM, White CM, Coleman CI. Association between perioperative NSAID use and postcardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF Suppression Trials (AFIST) I, II, and III. Curr Med Res Opinion 2008;24:1131-1136.
119. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N engl J Med 2005;352:1081-91.
120. Prasongsukarn K, Abel JG, Jamieson E, et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thor Cardiovasc Surg 2005;130:193-198.
121. Halonen J, Halonen P, Jarvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery- a randomized controlled trial. J Am Med Assoc 2007;297:1562-1567.
122. Chaney MA, Nikolov MP, Blakeman B, Bakhos M, Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998;87:27-33.
123. Halvorsen P, Raeder J, White PF, et al. The effect of dexamethasone on side effects after coronary revascularization procedures. Anesth Analg 2003;96:1578-1583. (Pubitemid 36623109)
124. Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. eur Heart J 2008;29:2952-2960.
125. Baker WL, White CM, Kluger J, Denowitz A, Konecny CP, Coleman CI. effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm 2007;4:461-468.
126. Sano T, Morita S, Masuda M, Yasui H. Minor infection encouraged by steroid administration during cardiac surgery. Asian Cardiovasc Thorac Ann 2006;14:505-510. (Pubitemid 44883683)
127. Consoli A, Devangelio E. Thiazolidinediones and inflammation. lupus 2005;14:794-797.
128. Ricote M, Li AC, Wilson TM, et al. The peroxisome proliferators-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
129. White CM, Sander S, Coleman CI, Gallagher R, Takata H, Humphrey C, et al. Impact of epicardial anterior fat pad retention on post-cardiothoracic surgery atrial fibrillation incidence: the atrial fibrillation suppression trial III. J Amer Col Cardiol 2007;49:298-303.
130. Anglade MW, Kluger J, White M, Aberle J, Coleman CI. Thiazolidinedione use and post-operative atrial fibrillation a US nested case-control study. Curr Med Res Opinion 2007;23(11):2849-2855.
131. Kris-Etherton PM, Harris WS, Appel LJ. Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. 106 2002(2747-2757).
132. Korantzopoulos P, Kolettis TM, Goudevenos JA. Effects of N-3 fatty acids on postoperative atrial fibrillation following coronary artery bypass surgery. J Amer Col Card 2006;47(2):467 (Letter).
133. Calo L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Amer Col Cardiol 2005;45:1723-1728.
134. Korantzopoulos P, Kolettis TM, Kountouris E, et al. Oral vitamin C administration reduces early recurrences rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 2005;102:321-326.
135. Carnes CA, Ching MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:e32-38.
136. Eslami M, Badkoubeh RS, Mousavi M, et al. Oral ascorbic acid in combination with β-blockers. Texas Heart J 2007;34:268-274.
137. Carnes CA, Janssen PM, Ruehr ML, et al. Atrial glutathione content, calcium current, and contractility. J Biol Chem 2007;282:28063-28073.
138. El-Hamamsy I, Stevens LM, Carrier M, et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thor Cardiovasc Surg 2007;133(1):7-12.
139. Ozaydin M, Peker O, Erdogan D, et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008;29:625-631.
140. Cavolli R, Kaya K, Aslan A, et al. Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study. Circulation 2008;118:476-481.
141. Klemperer JD, Klein IL, Ojamaa K, et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 1996;61(5):1323-1327.
142. Reichert MG, Verzino KC. Triiodothyronine supplementation in patients undergoing cardiopulmonary bypass. Pharmacother 2001;21(11):1368-1374. (Pubitemid 33051249)
143. Klemperer JD, Klein IL, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. NEJM 1995;333:1522-1527.